Ole Mogensen

ORCID: 0000-0001-7655-9909 · 3 papers in corpus · active 2008-2024

Study types

  • other 2
  • article 1

Condition tags

  • endometriosis 3
other 2024
Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study
Gynecologic oncology ·doi:10.1016/j.ygyno.2024.01.049

INTRODUCTION: It is unclear if sentinel node (SLN) mapping can replace pelvic- (PLD) and paraaortic lymphadenectomy (PALD) for high-risk endometrial cancer (EC). A diagnostically safe surgical algorithm, taking failed mapping cases into acc…

other 2023
The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer
Gynecologic oncology ·doi:10.1016/j.ygyno.2023.02.013

OBJECTIVE: The SENTIREC-endo study aims to investigate risks and benefits of a national protocolled adoption of sentinel lymph node (SLN) mapping in women with early-stage low-grade endometrial cancer (EC) with low- (LR) and intermediate-ri…

article 2008
Expression of the Epidermal Growth Factor System in Eutopic Endometrium from Women with Endometriosis Differs from That in Endometrium from Healthy Women
Gynecologic and obstetric investigation ·doi:10.1159/000167798

BACKGROUND: The epidermal growth factor (EGF) system comprises four receptors, HER1-4, and several ligands, and is cyclically expressed in endometrium from healthy fertile women. Our aim is to identify differences in expression of the EGF s…